PRESS RELEASE published on 02/23/2024 at 17:36, 1 year 9 months ago Research Dynamics: Report on CPH: FY2023 earnings update Research Dynamics report analyzes CPH Group's FY2023 earnings update, noting a decline in sales and profitability due to high base effect. Despite challenges, Chemistry and Packaging divisions performed well. CPH settled corporate bond and invested in capacity expansion. Uncertainties in economic outlook for FY2024. Valuation suggests slight upside potential Sales Decline CPH Group Research Dynamics FY2023 Earnings Uncertainties
BRIEF published on 02/23/2024 at 17:36, 1 year 9 months ago The CPH Group achieves a resilient performance for the financial year 2023 Financial Results 2023 CPH Group Paper Division Chemicals Division Packaging Division
PRESS RELEASE published on 09/29/2023 at 07:44, 2 years 2 months ago Research Dynamics - Report on CPHN: Investor Day Update
PRESS RELEASE published on 07/24/2023 at 08:28, 2 years 4 months ago Research Dynamics- Report on CPH: HY2023 earnings update
PRESS RELEASE published on 02/27/2023 at 07:33, 2 years 9 months ago Research Dynamics- Report on CPH: FY2022 earnings update
Published on 12/05/2025 at 02:35, 4 hours 53 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 28 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 23 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 28 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 28 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 58 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 37 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 3 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 13 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:00, 13 hours 28 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 43 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 44 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025